Hyaluronidase Market is Set to Grow at Staggering CAGR of 9.3% to Reach US$ 1,896.8 Million By 2032 | Astute Analytica [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
Beyond aesthetic medicine, hyaluronidase is finding new applications in fields such as oncology, immunology, and surgery. The field of regenerative medicine is another area where hyaluronidase is expected to play a significant role New Delhi, June 04, 2024 (GLOBE NEWSWIRE) -- The global hyaluronidase market exhibited a valuation of US$ 852.0 million in 2023, and it is projected to reach a market valuation of US$ 1,896.8 million by 2032 at a CAGR of 9.3% during the forecast period of 2024-2032. The global dermatology market was valued at around US$ 23 billion in 2024, showcasing the significant scale and impact of dermatological treatments worldwide. Over 5 million cases of non-melanoma skin cancer are treated in the U.S. annually, highlighting the extensive use of dermatological procedures. Cosmetic procedures have been growing at a rate of approximately 5-6% annually worldwide, driven by increasing demand for aesthetic treatments. Acne, one of the most common skin conditions, aff
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals? [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 8/7/24 - Beat
AMPH
Sec Filings
- 9/17/24 - Form 4
- 9/16/24 - Form 4
- 9/6/24 - Form 4
- AMPH's page on the SEC website